Alexandria Real Estate to Sell Boston Lab Tower by 2026

The developer aims to save $136 million as it halts office-to-lab conversions to reduce construction spending.

Updated on Oct. 28, 2026 in Commercial

Alexandria Real Estate to Sell Boston Lab Tower by 2026

Live Poll

Is now a good time to invest in major commercial property development in your area?

Alexandria Real Estate Equities plans to sell its 13-story, 339,668-square-foot lab tower at 421 Park Drive in Boston. The sale to an institutional investor is expected to close in the fourth quarter of 2026, marking a significant cost-cutting measure for the developer.

Why it matters

This divestment signals a strategic shift for Alexandria as it seeks to reduce expenses by canceling office-to-lab conversions. The move highlights the broader cooling of speculative lab-space construction in the Boston area.

Alexandria expects to shed $136 million in liability by offloading the tower, while also saving $220 million through reduced construction at the Arsenal on the Charles. The Fenway complex, which includes 421 Park Drive, currently maintains a 74 percent occupancy rate.

The players

Alexandria Real Estate Equities

A major real estate investment trust specializing in collaborative science and technology campuses.

Boston Children's Hospital

A prominent pediatric medical center and research institution based in the Boston area.

The details

The 421 Park Drive facility remains in a core-and-shell state, requiring significant interior work to reach final lab specifications. By selling the building to an institutional investor, Alexandria shifts the burden of the remaining $136 million in interior construction costs. This aligns with the firm's broader strategy to pull back on capital-intensive laboratory conversions in the current market.

Timeline

  1. Boston Children's Hospital acquired a 268,000-square-foot condo portion of the tower in 2023.

  2. The sale of the 421 Park Drive tower is projected to close in the fourth quarter of 2026.

The Home Front

This transition highlights the recent plateau in the Boston life science market, where high development costs have replaced the rapid expansion seen in previous years. The shift reflects a wider industry pivot toward capital preservation in the wake of shifting commercial real estate valuations.

Local property owners should keep an eye on how these large-scale commercial shifts influence long-term neighborhood revitalization in the Fenway area. While this sale is a business transaction, residents may notice changes in the construction timeline and activity levels at this site through 2026.

The takeaway

The move to sell the Park Drive lab tower underscores how current market conditions are forcing developers to prioritize liquidity over large construction projects. Investors and observers should track the completion of the tower sale in the fourth quarter of 2026 for further signs of market stabilization.

Further reading

For more updates on how business and development trends affect the city, see Boston Commercial.

Source note: This article includes information reported by Banker & Tradesman.

Live Poll

Is now a good time to invest in major commercial property development in your area?